ECOG-ACRIN EA8143

Primary Category:

Treatment Protocols

Disease Category:

Genitourinary, Renal

Status:

Open

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients with Localized Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)

Eligible for screening study DCP 001

NCT#03055013

Quality of Life (QOL) component reached its accrual goal. Therefore, QOL is closed  to new patient accrual effective June 19, 2020.

Site Delegation of Tasks Log required prior to registration of any patients.